VAIA
MDGL icon

Virtus Alternative Investment Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-45
Closed -$5K – 135
2020
Q4 		$5K Sell
45
-44
-49% -$5.38K 0.07% 259
2020
Q3 		$11K Sell
89
-73
-45% -$7.93K 0.2% 169
2020
Q2 		$18K Sell
162
-152
-48% -$14.9K 0.28% 69
2020
Q1 		$21K Buy
314
+224
+249% +$18.7K 0.29% 195
2019
Q4 		$8K Buy
+90
New +$8.73K 0.12% 233

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Virtus Alternative Investment Advisers's MDGL Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2021, closing a stake of 45 shares — an estimated $5K sold.

Virtus Alternative Investment Advisers first reported a position in MDGL in Q4 2019 and held it in 5 quarters. The position peaked at $21K in Q1 2020. 137 funds tracked by Wall St. Rank hold MDGL as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Madrigal Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 45 Madrigal Pharmaceuticals shares in Q1 2021, an estimated $5K.
  • Virtus Alternative Investment Advisers first reported a position in Madrigal Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's Madrigal Pharmaceuticals position peaked at $21K in Q1 2020.
  • 137 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.